支持循证轮状病毒疫苗引入决策与实施:来自8个Gavi合格国家的经验
尽管世界卫生组织2009年推荐所有国家将轮状病毒疫苗(RVV)纳入国家免疫规划,但截至2015年底仅81个国家引入。轮状病毒加速疫苗引入网络(RAVIN)于2016年成立,为8个Gavi合格国家提供支持。至2020年9月项目结束时,8个国家中5个成功将RVV纳入常规儿童免疫规划。
要点
- 截至2015年底仅81国引入轮状病毒疫苗,数百万儿童面临轮状病毒病和死亡风险。
- RAVIN于2016年成立,支持8个Gavi合格国家进行循证免疫决策和RVV引入准备。
- 至2020年9月项目结束,8个重点国家中5个成功将RVV纳入常规儿童免疫规划。
核心结论
- RAVIN项目支持8个Gavi合格国家进行循证RVV引入决策与实施,至2020年9月项目结束时5个国家成功引入RVV。
研究设计与样本
- 项目报告:轮状病毒加速疫苗引入网络(RAVIN)于2016年成立,支持8个Gavi合格国家(阿富汗、孟加拉国、贝宁、柬埔寨、刚果民主共和国、老挝人民民主共和国、缅甸、尼泊尔)。
- 2016-2020年期间,RAVIN与各国政府和伙伴合作,支持循证免疫决策、RVV引入准备与实施以及多边协调。
主要发现
- 截至2015年底,81个国家已将RVV纳入国家免疫规划。
- 至2020年9月项目结束时,8个RAVIN重点国家中5个成功将RVV纳入常规儿童免疫规划。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Despite the 2009 World Health Organization recommendation that all countries introduce rotavirus vaccines (RVV) into their national immunization programs, just 81 countries had introduced RVV by the end of 2015, leaving millions of children at risk for rotavirus morbidity and mortality. In response, the Rotavirus Accelerated Vaccine Introduction Network (RAVIN) was established in 2016 to provide support to eight Gavi-eligible countries that had yet to make an RVV introduction decision and/or had requested technical assistance with RVV preparations: Afghanistan, Bangladesh, Benin, Cambodia, Democratic Republic of Congo, Lao People's Democratic Republic, Myanmar, and Nepal. During 2016-2020, RAVIN worked with country governments and partners to support evidence-based immunization decision-making, RVV introduction preparation and implementation, and multilateral coordination. By the September 2020 program close-out, five of the eight RAVIN focus countries successfully introduced RVV into their routine childhood immunization programs. We report on the RAVIN approach, describe how the project responded collectively to an evolving RVV product landscape, synthesize common characteristics of the RAVIN country experiences, highlight key lessons learned, and outline the unfinished agenda to inform future new vaccine introduction efforts by countries and global partners.
引用
- Jennings MC, Sauer M, Manchester C, et al. Supporting evidence-based rotavirus vaccine introduction decision-making and implementation: Lessons from 8 Gavi-eligible countries. Vaccine. 2023. PMID: 38042696. doi:10.1016/j.vaccine.2023.11.035
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。